Skip to main navigation
AvidXchange logo
  • Overview
  • News
  • Events & Presentations
    • Events
    • Presentations
  • Corporate Governance
    • Our Environmental, Social, Governance (ESG) commitment
    • Governance Overview
    • Leadership
    • Committee Composition
  • Financial Info
    • SEC Filings
    • Earnings
  • Shareholder Services
    • Investor FAQs
    • Contact Us

Investor Relations

Corporate Profile

An RNA platform to help feed the world and keep it healthy.
Environmental, Social, Governance (ESG) responsibilities are core to this purpose.

 

Latest news releases

Featured Releases

08.15.22
GreenLight Biosciences Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress
08.12.22
GreenLight Biosciences announces $109 million financing
08.01.22
GreenLight Biosciences and Samsung Biologics complete first commercial-scale engineering run for mRNA Covid-19 vaccine
  • View All News
Latest events

Presentations

Investor presentation - August 10th 2022
Impact deck - June 14th 2022
Analyst teach-in (plant and animal health) - January 20th 2022
  • View All Presentations
Latest earnings

SEC Filings

Filing date Form
09.26.22 424B3
09.26.22 8-K
09.26.22 S-1
  • View All Filings

 

To stay updated with GreenLight news

Sign Up

Shareholder Tools

What we do

  • Platform
  • Human Health
  • Plant and Animal Health

Quick links

  • Careers
  • Contact
  • Partners
  • Press kit

Join us on Social

  • LinkedIn
  • Twitter

Footer Bottom

  • Privacy Policy
  • All rights reserved. 2022 GreenLight Biosciences